Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitorsGiulia Minetti, Prem Puri, Silvia Fortuni et al.|Nature Medicine|2006Cited by 339
Targeted ablation of IKK2 improves skeletal muscle strength, maintains mass, and promotes regenerationFoteini Mourkioti, Nadia Rosenthal, Paschalis Kratsios et al.|Journal of Clinical Investigation|2006Cited by 311
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trialEugenio Mercuri, Katie Groves, Francesco Muntoni et al.|The Lancet Neurology|2021Cited by 260